[edit]
XAI-MeD: Explainable Knowledge Guided Neuro-Symbolic Framework for Domain Generalization and Rare Class Detection in Medical Imaging
Proceedings of The Second AAAI Bridge Program on AI for Medicine and Healthcare, PMLR 317:265-274, 2026.
Abstract
Explainability, domain generalization, and rare-class reliability are critical challenges in medical AI, where deep models often fail under real-world distribution shifts and exhibit bias against infrequent clinical conditions. This paper introduces XAI-MeD, an explainable medical AI framework that integrates clinically accurate expert knowledge into deep learning through a unified neuro-symbolic architecture. XAI-MeD is designed to improve robustness under distribution shift, enhance rare-class sensitivity, and deliver transparent, clinically aligned interpretations. The framework encodes clinical expertise as logical connectives over atomic medical propositions, transforming them into machine-checkable, classspecific rules. Their diagnostic utility is quantified through weighted feature satisfaction scores, enabling a symbolic reasoning branch that complements neural predictions. A confidence-weighted fusion integrates symbolic and deep outputs, while a Hunt-inspired adaptive routing mechanism—guided by Entropy Imbalance Gain (EIG) and Rare-Class Gini mitigates class imbalance, high intra-class variability, and uncertainty. We evaluate XAI-MeD across diverse modalities, on four challenging tasks: (i) Seizure Onset Zone (SOZ) localization from rs-fMRI, (ii) Diabetic Retinopathy grading, across 6 multicenter datasets demonstrate substantial performance improvements, including 6% gains in cross- domain generalization and a 10% improved rare-class F1 score far outperforming state-of-the-art deep learning baselines. Ablation studies confirm that the clinically grounded symbolic components act as effective regularizers, ensuring robustness to distribution shifts. XAI-MeD thus provides a principled, clinically faithful, and interpretable approach to multimodal medical AI.